Med-tech firms raising money in public or private financings, including: Avail Medsystems, Cerebral, Hancock Jaffe Laboratories, Nanostring Technologies.

New hires and promotions in the med-tech industry, including: Akili, Cardiologs, Equinox Ophthalmic, Indago, Titan Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aprea, Arca, Arch, Biomarin, Eton, Lilly, OWP, Pluristem, Polarean, TLC, Y-Mabs.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aetion, Anpac, Bintai Kinden, Biogen, Calithera, Citius, Complix, Denali, Foundation, Generex, Greenwich, Innovent, Kindred, Lilly, Mapi, Novellus, Nugenerex, Olix, Provention, Renibus, Spartina, Sunovion, Sunshine, Théa, UCB, Urovant, Vaccibody, Vaxart.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abfero, Achieve, BMS, Epizyme, Ilya, Immunitybio, Lilly, Nantkwest, Napo, Onconano, Pfizer, Redhill, Stoke, Teva.

Biopharmas raising money in public or private financings, including: Arcutis, Benitec, C4, Codiak, Kiromic, Nuo, Oncology Venture Phenomic, Springworks.

New hires and promotions in the biopharma industry, including: Achilles, Akili, Ashvattha, Carmell, In8bio, Inositec, Kahr, Polyneuron, Radius.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Baylx, Carsgen, I-Mab, Innovation, Kyowa Kirin, Medimetriks, Neuren, Organicell, Otsuka, Taigen, Windtree.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Astrazeneca, Corvus, Curevac, Eisai, Enlivex, FSD, Harbour Biomed, Johnson & Johnson, Kancera, Kyowa Kirin, Medincell, Mei, Moderna, Regeneron, Revelation, Revive, Shanghai Junshi, Zai Lab.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Allele, Axim, Bone, Casi, Chelation Partners, Cognate Bioservices, Eli Lilly, Evaxion, Fibrogenesis, Fosun, Juventas Cell Therapy, Koligo, Lakes, Lexaria Biosciences, Link Health, Luca Science, Luminarie Canada, Medicure, Moleculin Biotech, Navigo Proteins, Neurorx, Orgenesis, Pharco, Pluristem, Polyphor, R4D, Recce, Reliance Life Sciences, Relief, Repligen, Scancell, Serum Institute of India, Shenzhen Pregene, Sorrento, Taigen, University of Oxford, Vaxxas, Viralclear.